Karen‐Lise Garm Spindler

Quantitative Cell-Free DNA, <i>KRAS</i> , and <i>BRAF</i> Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan

Karen‐Lise Garm Spindler, Niels Pallisgaard, Ivan R. Vogelius et al. · Clinical Cancer Research · 2012 · 251 citations · Full text

The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer

Anneli Dowler Nygaard, Karen‐Lise Garm Spindler, Niels Pallisgaard et al. · Lung Cancer · 2012 · 125 citations

Tumor Biology, Plasma Dna, Oncology +12

Can we <i>S</i> ave the rectum by watchful waiting or <i>T</i> rans <i>A</i> nal microsurgery following (chemo) <i>R</i> adiotherapy versus <i>T</i> otal mesorectal excision for early <i>RE</i> ctal <i>C</i> ancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study

Anouk J. M. Rombouts, Issam Al‐Najami, Natalie L. Abbott et al. · BMJ Open · 2017 · 100 citations · Full text

Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer

Karen‐Lise Garm Spindler, Ane Appelt, Niels Pallisgaard et al. · International Journal of Cancer · 2014 · 99 citations · Full text

Changes in mutational status during third‐line treatment for metastatic colorectal cancer—Results of consecutive measurement of cell free DNA, <i>KRAS</i> and <i>BRAF</i> in the plasma

Karen‐Lise Garm Spindler, Niels Pallisgaard, Rikke Fredslund Andersen et al. · International Journal of Cancer · 2014 · 94 citations · Full text

Pathology, Cell Free Dna, Tumor Biology +17